Stay updated on XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page.

Latest updates to the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page
- Check6 days agoChange DetectedThe revision entry was updated from v3.4.2 to v3.4.3 in the page's history. This indicates a minor site update and does not change the study record content or data shown.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the history, and older notices like the funding-lapse message and Revision: v3.4.1 were removed; these are administrative updates and do not alter trial data or how the study is presented. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check41 days agoChange DetectedAdded a new revision entry (v3.4.1) to the Record History and removed the previous entry (v3.4.0). Also included a government funding lapse notice on the page.SummaryDifference0.7%

- Check48 days agoChange DetectedGlossary display added and color-coding explanations (green for additions, red for deletions) are now shown, along with a revision tag updated to v3.4.0 and minor text adjustments such as No FEAR Act Data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check62 days agoChange DetectedRevision v3.3.4 was added to the study history and Revision v3.3.3 was removed, reflecting a change in the record's versioning. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAn added revision note (v3.3.3) and the removal of the HHS Vulnerability Disclosure, along with a prior revision note (v3.3.2), are administrative updates to the page footer; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page.